2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Haugen, Bryan R., Alexander, Erik K., Bible, Keith C., Doherty, Gerard M., Mandel, Susan J., Nikiforov, Yuri E., Pacini, Furio, Randolph, Gregory W. +8 more·2016·Thyroid®

Cites (1,326)

Items 801–1,000 of 1,326

  1. Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels
    Sophie Leboulleux, Intidhar El Bez, Isabelle Borget, Manel Elleuch, Désirèe Deandreis, Abir Al Ghuzlan, C. Chougnet, François Bidault, H. Mirghani, J. Lumbroso et al. · 2012 · Thyroid
  2. Role of FDG PET/CT and Chest CT in the Follow-up of Lung Lesions Treated with Radiofrequency Ablation
    Désirèe Deandreis, Sophie Leboulleux, Clarisse Dromain · 2010 · Radiology
  3. Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension
    Michael Rivera, Julio C. Ricarte‐Filho, Robert Michael Tuttle, Ian Ganly, Ashok R. Shaha, Jeffrey A. Knauf, James A. Fagin, Ronald A. Ghossein · 2010 · Thyroid
  4. Is 18 F-Fluorodeoxyglucose–PET/CT Useful for the Presurgical Characterization of Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytology?
    Désirèe Deandreis, Abir Al Ghuzlan, Anne Auperin, Philippe R. Vielh, Bernard Caillou, L. Chami, J. Lumbroso, Jean‐Paul Travagli, Dana M. Hartl, Éric Baudin et al. · 2012 · Thyroid
  5. Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: The Next UK National Cancer Research Network Randomised Trial following HiLo
    Ujjal K. Mallick, Clive Harmer, Allan K. Hackshaw, Laura Moss · 2012 · Clinical Oncology
  6. Value of Postoperative Thyroglobulin and Ultrasonography for the Indication of Ablation and 131 I Activity in Patients with Thyroid Cancer and Low Risk of Recurrence
    Pedro Weslley Rosário, Arthur Cezar Malard Xavier, Maria Regina Calsolari · 2010 · Thyroid
  7. Poorly differentiated thyroid carcinomas: application of the T urin proposal provides prognostic results similar to those from the assessment of high‐grade features
    Viviane Gnemmi, Florence Renaud, Christine Do Cao et al. · 2013 · Histopathology
  8. Ablation of Skeletal Metastases: Current Status
    A. Nicholas Kurup, Matthew R. Callstrom · 2010 · Journal of Vascular and Interventional Radiology
  9. Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients
    B. Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, Xavier Carrat, Philippe Lagarde, Anne Laure Cazeau, Antoîne Italiano, Paul Sargos, Guy Kantor, Hugues Loiseau et al. · 2013 · Thyroid
  10. Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review
    Anna M. Sawka, Irada Ibrahim-zada, Philip Galacgac, Richard W. C. Tsang, James D. Brierley, Shereen Ezzat, David Paul Goldstein · 2010 · Thyroid
  11. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
    Annalisa Iervasi, Giorgio Iervasi, Marco Ferdeghini, C. Solimeo, Antonio Bottoni, Leonardo Rossi, Chiara Colato, G.C. Zucchelli · 2007 · Clinical Endocrinology
  12. Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases
    Tatsuya Higashi, Ryuichi Nishii, Shigeki Yamada, Yuji Nakamoto, Koichi Ishizu, Shigeto Kawase, Kaori Togashi, Satoshi Itasaka, Masahiro Hiraoka, Takashi Misaki et al. · 2011 · Journal of Nuclear Medicine
  13. A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin from Patient Samples Containing Antithyroglobulin Autoantibodies
    Nigel J. Clarke, Yanni Zhang, Richard E. Reitz · 2012 · Journal of Investigative Medicine
  14. Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative
    Mark L. Urken, Mira Milas, Gregory William Randolph, Ralph Patrick Tufano, Donald A. Bergman, Victor Joseph Bernet, Elise M. Brett, James D. Brierley, Rhoda H. Cobin, Gerard M. Doherty et al. · 2014 · Head & Neck
  15. Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis
    Weiwei Cheng, Chao Ma, Hongliang Fu, Jianing Li, Suyun Chen, Shuqi Wu, Hui Wang · 2013 · The Journal of Clinical Endocrinology & Metabolism
  16. Quality Assurance in Molecular Genetic Testing Laboratories
    Margaret M. McGovern · 1999 · JAMA
  17. Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans
    Eunkyung Park, June-Key Chung, Il Han Lim, Do Joon Park, Dong Soo Lee, Myung Chul Lee, Bo Youn Cho · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  18. Tumor angiogenesis as a prognostic factor in ovarian carcinoma
    W Schoell, Doris Pieber, Olaf Reich, MANFRED LAHOUSEN, Mike F. Janicek, Fatih Güçer, Raimund Winter · 1997 · Cancer
  19. Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal
    Rossella Elisei, Martin Jean Schlumberger, A. A. Driedger, Christoph Reiners, Richard T. Kloos, Steven I. Sherman, Bryan R. Haugen, C. Corone, Eleonora Molinaro, Lucia Grasso et al. · 2009 · The Journal of Clinical Endocrinology & Metabolism
  20. The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring
    Aubrey A. Carhill, Maria E. Cabanillas, Camilo Jiménez, Steven Gerard Waguespack, Mouhammed Amir Habra, Mimi I-Nan Hu, Anita Kuo Ying, Rena Vassilopoulou‐Sellin, Robert F. Gagel, Steven I. Sherman et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
  21. Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
    C. Nascimento, Isabelle Borget, Abir Al Ghuzlan, Désirèe Deandreis, L. Chami, J P Travagli, Dana M. Hartl, J. Lumbroso, C. Chougnet, Ludovic Lacroix et al. · 2010 · Endocrine Related Cancer
  22. Thyroid Nodules ≥4 cm: Can Ultrasound and Cytology Reliably Exclude Cancer? Reply
    Linwah Yip · 2014 · World Journal of Surgery
  23. The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
    Lilah F. Morris, Alan D. Waxman, Glenn David Braunstein · 2001 · The Journal of Clinical Endocrinology & Metabolism
  24. Cancer-Related Worry in Canadian Thyroid Cancer Survivors
    Lauren Bresner, Rita Banach, Gary Rodin, Lehana Thabane, Shereen Ezzat, Anna M. Sawka · 2014 · The Journal of Clinical Endocrinology & Metabolism
  25. Differentiated thyroid cancer long-term impact of initial therapy.
    Ernest L. Mazzaferri, Sissy Meihua Jhiang · 1995 · PubMed
  26. Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours
    Bryan R. Haugen, Whitney W. Woodmansee, Michael T. McDermott · 2002 · Clinical Endocrinology
  27. Management of the recurrent laryngeal nerve in suspected and proven thyroid cancer
    S FALK, Thomas V. McCaffrey · 1995 · Otolaryngology
  28. Safety of Modified Radical Neck Dissection for Differentiated Thyroid Carcinoma
    Michael Elliot Kupferman, D. Michael Patterson, Susan J. Mandel, Virginia A. LiVolsi, Randal S. Weber · 2004 · The Laryngoscope
  29. Sonographic Findings in the Surgical Bed After Thyroidectomy
    Jung Hee Shin, Boo‐Kyung Han, Eun Young Ko · 2007 · Journal of Ultrasound in Medicine
  30. Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, Jean-Pierre Rame, Pascaline Berthet, E. Babin, Philippe Icard, Guy Samama, Françoise Galateau-Sallé, JACQUES A. MAHOUDEAU et al. · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  31. Radioiodine Therapy for Thyroid Cancer and Hyperthyroidism in Patients with End-Stage Renal Disease on Hemodialysis
    Jennifer P. Holst, Kenneth Dale Burman, Frank Atkins, Jason G. Umans, Jacqueline Jonklaas · 2005 · Thyroid
  32. Lymph Node Ratio of the Central Compartment is a Significant Predictor for Locoregional Recurrence After Prophylactic Central Neck Dissection in Patients with Thyroid Papillary Carcinoma
    In Sun Ryu, Chan Il Song, Seung‐Ho Choi, Jong‐Lyel Roh, Soon Yuhl Nam, Sang Yoon Kim · 2013 · Annals of Surgical Oncology
  33. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma
    Stefanie Dießl, Barbara Holzberger, Uwe Mäder, Inge Grelle, Johannes W. A. Smit, Andreas Konrad Buck, Christoph Reiners, Frederik A. Verburg · 2011 · Clinical Endocrinology
  34. Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Follow-Up of Papillary or Follicular Thyroid Cancer
    Lotty Hooft, Otto S. Hoekstra, W.L.J.M. Devillé, Paul T.A.M. Lips, Gerrit J. J. Teule, Maarten Boers, Maurits W. van Tulder · 2001 · The Journal of Clinical Endocrinology & Metabolism
  35. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation
    Ha T.T. Phan, Pieter L. Jager, Jacqueline E. van der Wal, Wim J. Sluiter, John Th. M. Plukker, Rudi Dierckx, Bruce H. R. Wolffenbuttel, Thera P. Links · 2008 · European Journal of Endocrinology
  36. Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin
    Leonard Wartofsky · 2002 · Thyroid
  37. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance
    Won Sang Yoo, Hoon Sung Choi, Sun Wook Cho, Jae Hoon Moon, Kyung Won Kim, Hyo Jin Park, So Yeon Park, Sang Il Choi, Sung Hee Choi, Soo Kyung Lim et al. · 2013 · Clinical Endocrinology
  38. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
    Gary L. Clayman, Thomas D. Shellenberger, Lawrence E. Ginsberg · 2009 · Head & Neck
  39. Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma
    Alon Vaisman, Steven Orlov, Jonathan Yip, Cindy Hu, Terence Lim, Mark Dowar, Jeremy L. Freeman, Paul G. Walfish · 2010 · Head & Neck
  40. Long-Term Thyrotropin-Suppressive Therapy with Levothyroxine Impairs Small and Large Artery Elasticity and Increases Left Ventricular Mass in Patients with Thyroid Carcinoma
    Marina Shargorodsky, S. Serov, Dov Gavish, Eyal Leibovitz, David Harpaz, Reuven Zimlichman · 2006 · Thyroid
  41. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Preoperative Assessment of Cytologically Indeterminate Thyroid Nodules
    Fernando Moreno Sebastianes, Juliano J. Cerci, Patrícia H. Zanoni, José Soares, L. K Chibana, Eduardo Kiyoshi Tomimori, R. Y. A. Camargo, Marisa Izaki, Maria Clementina Pinto Giorgi, José Eluf‐Neto et al. · 2007 · The Journal of Clinical Endocrinology & Metabolism
  42. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma
    Ergün Erdem, Mehmet Ali Gülçelik, Bekir Kuru, Haluk Alagöl · 2003 · European Journal of Surgical Oncology
  43. Characterization of thyroid nodules using the proposed thyroid imaging reporting and data system (TI‐RADS)
    Shih‐Ping Cheng, Jie-Jen Lee, Jiun‐Lu Lin, Shih‐Ming Chuang, Ming-Nan Chien, Chien‐Liang Liu · 2012 · Head & Neck
  44. Twenty-Five Years After Chernobyl: Outcome of Radioiodine Treatment in Children and Adolescents With Very High-Risk Radiation-Induced Differentiated Thyroid Carcinoma
    Christoph Reiners, Johannes Biko, Heribert Haenscheid · 2013 · The Journal of Clinical Endocrinology & Metabolism
  45. Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma
    Yorihisa Orita, Iwao Sugitani, Kazuhisa Toda · 2010 · Thyroid
  46. Pretherapeutic Staging of Hypopharyngeal Carcinoma: Clinical Findings, Computed Tomography, and Magnetic Resonance Imaging Compared With Histopathologic Evaluation
    Peter Zbären, Minerva Becker, Hubert Läng · 1997 · Archives of Otolaryngology - Head and Neck Surgery
  47. Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
    Richard J. Robbins, Shefali Srivastava, Ashok R. Shaha, Ronald A. Ghossein, Steven M. Larson, Martin Fleisher, Robert Michael Tuttle · 2004 · The Journal of Clinical Endocrinology & Metabolism
  48. Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer
    Kathryn G. Schuff, Stephen M. Weber, Babak Givi · 2008 · The Laryngoscope
  49. IONM-guided goiter surgery leading to two-stage thyroidectomy—indication and results
    Magnus Melin, Katharina Schwarz, Bernhard J. Lammers · 2012 · Langenbeck s Archives of Surgery
  50. Treatment and prognostic factors of papillary thyroid microcarcinoma
    Davide Giordano, Paolo Gradoni, Gabriele Oretti · 2010 · Clinical Otolaryngology
  51. Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
    Lutz Stefan Freudenberg, Walter Jentzen, Alexander R. Stahl · 2011 · European Journal of Nuclear Medicine and Molecular Imaging
  52. Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration
    Milena Braga, Matthew David Ringel, David S. Cooper · 2001 · The Journal of Clinical Endocrinology & Metabolism
  53. Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors
    Nijaguna B. Prasad, Helina Somervell, Ralph Patrick Tufano et al. · 2008 · Clinical Cancer Research
  54. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma
    Maarten F. de Boer, Bart H.P. van den Borne, Jean F. A. Pruyn, Richard M. Ryckman, Lex Volovics, Paul P. M. Knegt, Cees A. Meeuwis, Ilse Mesters, Carel D. A. Verwoerd · 1998 · Cancer
  55. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery
    Marko Hočevar, M. Auersperg, L. Stanovnik · 1997 · European Journal of Surgical Oncology
  56. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy
    Lang, Brian Hung-Hin, Wong, Irene Oi Ling, Wong, Kai Pun, Cowling, Benjamin J., Wan, Koon-Yat · 2012 · Surgery
  57. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
    Christian Pötzi, Abbas Moameni, Georgios Karanikas, J. Preitfellner, Alexander Becherer, Christian Pirich, Robert Dudczak · 2006 · Clinical Endocrinology
  58. Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance
    Jeffrey F. Krane, Ritu Nayar, Andrew A. Renshaw · 2009 · Springer eBooks
  59. Thyroid Nodules with Bethesda System III Cytology: Can Ultrasonography Guide the Next Step?
    Hye Mi Gweon, Eun Ju Son, Ji Hyun Youk · 2013 · Annals of Surgical Oncology
  60. BRAF V600E Mutation Analysis of Thyroid Nodules Needle Aspirates in Relation to Their Ultrasongraphic Classification: A Potential Guide for Selection of Samples for Molecular Analysis
    Sang Yu Nam, Boo‐Kyung Han, Eun Young Ko, Seok Seon Kang, Soo Yeon Hahn, Ji‐Young Hwang, Mee Young Nam, Jong‐Won Kim, Jae Hoon Chung, Young Lyun Oh et al. · 2010 · Thyroid
  61. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features
    Ilaria Messuti, Stefania Corvisieri, Francesca Bardesono, Ida Rapa, Jessica Giorcelli, Riccardo Emanuele Pellerito, Marco Volante, Fabio Orlandi · 2014 · European Journal of Endocrinology
  62. Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma
    A. C. Chiu · 1997 · The Journal of Clinical Endocrinology & Metabolism
  63. Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin
    Francesco Latrofa, Debora Ricci, Lucia Montanelli, Roberto Rocchi, Paolo Piaggi, Eleonora Sisti, Lucia Grasso, Fulvio Basolo, Clara Ugolini, Aldo Pinchera et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
  64. Fine needle aspiration biopsy of thyroid nodules
    İrfan Serdar Arda · 2001 · Archives of Disease in Childhood
  65. The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules
    Bekir Kuru, Neşe Ersöz Gülçelik, Mehmet Ali Gülçelik · 2009 · Langenbeck s Archives of Surgery
  66. The Use of Preoperative Routine Measurement of Basal Serum Thyrocalcitonin in Candidates for Thyroidectomy due to Nodular Thyroid Disorders: Results from 2733 Consecutive Patients
    Guillaume Chambon, Caroline Alovisetti, Catherine Idoux-Louche, Christophe Reynaud, Michel Rodier, A.M. Guedj, Héliette Chapuis, Jean‐Gabriel Lallemant, Benjamin Lallemant · 2010 · The Journal of Clinical Endocrinology & Metabolism
  67. Papillary Thyroid Carcinomas with Lung Metastases
    Jen‐Der Lin, Tzu‐Chieh Chao, Shuo-Chi Chou, Chuen Hsueh · 2004 · Thyroid
  68. Radioactive Iodine Lobe Ablation as an Alternative to Completion Thyroidectomy for Follicular Carcinoma of the Thyroid
    Gregory William Randolph, Gilbert H. Daniels · 2002 · Thyroid
  69. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma
    Karin M. van Tol, J. M. Hew, P. L. Jager, A Vermey, Robin P. F. Dullaart, Thera P. Links · 2000 · Clinical Endocrinology
  70. Thyrotropin Suppressive Therapy in Thyroid Carcinoma: What Are the Targets?
    Georg E. Brabant · 2008 · The Journal of Clinical Endocrinology & Metabolism
  71. Targeting Mutant BRAF in Melanoma
    Ragini Reiney Kudchadkar, Kim H.T. Paraiso, Keiran S.M. Smalley · 2012 · The Cancer Journal
  72. Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances
    Martin Jean Schlumberger, Steven I. Sherman · 2009 · Thyroid
  73. Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT
    Ji Hyoung Seo, Sang Woo Lee, Byeong‐Cheol Ahn · 2009 · Clinical Endocrinology
  74. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma
    Ilya Sedliarou, Vladimir Saenko, Dmitry Lantsov, Tatiana Rogounovitch, Hiroyuki Namba, Aleksandr Abrosimov, Eugeny F. Lushnikov, Atsushi Kumagai, Masahiro Nakashima, Serik K. Meirmanov et al. · 2004 · International Journal of Oncology
  75. Tracheal Invasion by Thyroid Carcinoma
    Jichen Wang, Shodayu Takashima, Fumiyoshi Takayama, Satoshi Kawakami, Akitoshi Saito, Tsuyoshi Matsushita, Hideki Matsuba, Shinya Kobayashi · 2001 · American Journal of Roentgenology
  76. Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?
    Pedro Weslley Rosário, Álvaro Luís Barroso, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Tales Alvarenga Fagundes, Gustavo Penna, Saulo Purisch · 2004 · Clinical Nuclear Medicine
  77. External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer
    Daniel Ford, Selvaraj Giridharan, Chris McConkey, Andrew G. J. Hartley, Caroline Brammer, John C Watkinson, John Glaholm · 2003 · Clinical Oncology
  78. Preoperative Serum Thyroglobulin as a Useful Predictive Marker to Differentiate Follicular Thyroid Cancer from Benign Nodules in Indeterminate Nodules
    Eun Kyung Lee, Ki‐Wook Chung, Hye Sook Min, Tae Sung Kim, Tae Hyun Kim, Junsun Ryu, Yoo Seok Jung, Seok Ki Kim, You Jin Lee · 2012 · Journal of Korean Medical Science
  79. Radioiodine in the Treatment of Thyroid Cancer
    Douglas Van Nostrand, Leonard Wartofsky · 2007 · Endocrinology and Metabolism Clinics of North America
  80. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole‐body scan: comparative study
    Jung‐Min Koh, Eun Sook Kim, Jin Sook Ryu, Suck Joon Hong, Won Bae Kim, Young Kee Shong · 2003 · Clinical Endocrinology
  81. Handling of Thyroid Follicular Patterned Lesions
    Juan Rosaí · 2005 · Endocrine Pathology
  82. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma
    Hye Jeong Kim, Na Kyung Kim, Ji Hun Choi, Se Won Kim, Sang‐Man Jin, Sunghwan Suh, Ji Cheol Bae, Yong‐Ki Min, Jae Hoon Chung, Sun Wook Kim · 2012 · Clinical Endocrinology
  83. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
    Seyfettin Ilgan, Alper Özgür Karaçalıoğlu, Gökçe Kaan Ataç, Nuri Arslan, Emel Öztürk, Bengül Günalp, Mehmet Özgüven, Yüksel Pabuşçu · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  84. Ultrasonographic evaluation of thyroid nodules: comparison of ultrasonographic, cytological, and histopathological findings
    Kamile Gül, Reyhan Ersoy, Ahmet Dirikoç · 2009 · Endocrine
  85. The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer
    Kathleen O’Connell, Tina W. F. Yen, Francisco A. Quiroz, Douglas B. Evans, Tracy S. Wang · 2013 · Surgery
  86. BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases
    Vito Rodolico, Daniela Cabibi, Giuseppe Pizzolanti · 2007 · Cancer
  87. Value of Repeating A Nondiagnostic Thyroid Fine-Needle Aspiration Biopsy
    Israel B. Orija, Maria M. Pineyro, Charles V. Biscotti · 2007 · Endocrine Practice
  88. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients
    Yasuhiro Ito, Akira Miyauchi, Hideki Ishikawa · 2011 · Endocrine Journal
  89. Metastatic Minimally Invasive (Encapsulated) Follicular and Hurthle Cell Thyroid Carcinoma: A Study of 34 Patients
    Neal S. Goldstein, Peter F. Czako, James S. A. Neill · 2000 · Modern Pathology
  90. Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
    Frederik A. Verburg, Heribert Hänscheid, Johannes Biko, Maria Hategan, Michael Laßmann, Michael Christoph Kreissl, Christoph Reiners, Markus Luster · 2009 · European Journal of Nuclear Medicine and Molecular Imaging
  91. SERIAL SERUM THYROGLOBULIN MEASUREMENTS IN THE MANAGEMENT OF DIFFERENTIATED THYROID CARCINOMA
    E. G. Black, Michael C. Sheppard, R Hoffenberg · 1987 · Clinical Endocrinology
  92. Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma
    Babak Fallahi, Davood Beiki, Abbas Takavar, Armaghan Fard‐Esfahani, Kianoush Ansari Gilani, Mohsen Saghari, Mohammad Eftekhari · 2011 · Nuclear Medicine Communications
  93. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
    Jentzen, Walter, Balschuweit, Dorothee, Schmitz, Jochen, Freudenberg, Lutz, Eising, Ernst, Hilbel, Thomas, Bockisch, Andreas, Stahl, Alexander · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
  94. Cribriform‐morular variant of papillary thyroid carcinoma—Cytological and immunocytochemical findings of 18 cases
    Mitsuyoshi Hirokawa, Miyoko Maekawa, Seiji Kuma · 2010 · Diagnostic Cytopathology
  95. The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
    Martin Alexander Walter, Christian P. Turtschi, Christian J. A. Schindler, Peter Minnig, Jan Müller‐Brand, Beat Peter Müller-Stich · 2007 · Journal of Nuclear Medicine
  96. Positron emission tomography in thyroid cancer management
    Steven M. Larson, Richard J. Robbins · 2002 · Seminars in Roentgenology
  97. Circulating Thyrotropin Receptor mRNA as a Novel Marker of Thyroid Cancer
    Mira Milas, Joyce Shin, Manjula K. Gupta, Tomislav Novosel, Christian E. Nasr, Jennifer Brainard, Jamie C. Mitchell, Eren Berber, ALLAN E. SIPERSTEIN · 2010 · Annals of Surgery
  98. Reevaluation of the Impact of a Stringent Low-Iodine Diet on Ablation Rates in Radioiodine Treatment of Thyroid Carcinoma
    Lilah F. Morris, Matthew S. Wilder, Alan D. Waxman · 2001 · Thyroid
  99. Utility of Thyroglobulin measurement in fine-needle aspiration biopsy specimens of lymph nodes in the diagnosis of recurrent thyroid carcinoma
    Zubair Wahid Baloch, Julieta E. Barroeta, Janet Walsh, Prabodh K. Gupta, Virginia A. LiVolsi, Jill E. Langer, Susan J. Mandel · 2008 · CytoJournal
  100. Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence
    Jonathan Hugo, Eyal Robenshtok, Ravinder K. Grewal, Steven M. Larson, Robert Michael Tuttle · 2012 · Thyroid
  101. Interventional sialendoscopy for treatment of radioiodine‐induced sialadenitis
    Steven R. Bomeli, Barry M. Schaitkin, Ricardo Luis Carrau · 2009 · The Laryngoscope
  102. Value of external irradiation for locally advanced papillary thyroid cancer
    Tae Hyun Kim, Dae Sik Yang, Kwang‐Yoon Jung, Chul Yong Kim, Myung-Sun Choi · 2003 · International Journal of Radiation Oncology*Biology*Physics
  103. Invasive differentiated thyroid carcinoma: Tracheal resection and reconstruction procedures in the hands of the endocrine surgeon
    Thomas J. Musholt, Petra B. Musholt, Matthias Behrend, Rudolf Raab, Georg F. W. Scheumann, Jurgen L. Klempnauer · 1999 · Surgery
  104. Sonographic Differentiation of Partially Cystic Thyroid Nodules: A Prospective Study
    Dong Wook Kim, E.J. Lee, Hyun Sin In, S.J. Kim · 2010 · American Journal of Neuroradiology
  105. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas
    Jen‐Der Lin, Huang Mj, Brend Ray‐Sea Hsu · 2002 · Journal of Surgical Oncology
  106. Image-guided Ablation of Postsurgical Locoregional Recurrence of Biopsy-proven Well-differentiated Thyroid Carcinoma
    Jeffrey P. Guenette, Jack M. Monchik, Damian Edward Dupuy · 2013 · Journal of Vascular and Interventional Radiology
  107. Postablation 131I scintigraphy with neck and thorax SPECT–CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer
    Renaud Ciappuccini, Natacha Heutte, Géraldine Trzepla, Jean-Pierre Rame, Dominique Vaur, Nicolas Aide, Stéphane Bardet · 2011 · European Journal of Endocrinology
  108. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
    Karin M. van Tol, P.L. Jager, Elisabeth G.E. de Vries, DA Piers, HM Boezen, W.J. Sluiter, Robin P. F. Dullaart, TP Links · 2003 · European Journal of Endocrinology
  109. Recombinant Human Thyrotropin-Assisted Radioiodine Therapy for Patients with Metastatic Thyroid Cancer Who Could Not Elevate Endogenous Thyrotropin or Be Withdrawn from Thyroxine
    Richard J. Robbins, Albert A. Driedger, James A. Magner, The U.S. and Canadian Thyrogen Compassionate Use Program (TCUP) Investigator Group · 2006 · Thyroid
  110. Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive and Rapidly Progressive Thyroid Carcinomas
    Kenneth B. Ain, Charles Lee, Kevin D. Williams · 2007 · Thyroid
  111. The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid Cancer
    Ming-Kai Chen, Mona Yasrebi, Jason M. Samii, Lawrence H. Staib, Indukala Doddamane, David W. Cheng · 2012 · Thyroid
  112. Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma
    Edward B. Silberstein · 2007 · Journal of Nuclear Medicine
  113. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas1
    Julio Cesar Furlan, Yvan C. Bédard, Irving B. Rosen · 2004 · Journal of the American College of Surgeons
  114. Hemiplegia after Thyrotropin Alfa in a Hypothyroid Patient with Thyroid Carcinoma Metastatic to the Brain
    George E. Vargas, Harry L. Uy, Carlos Bazan, Theresa A. Guise, Jan Bruder · 1999 · The Journal of Clinical Endocrinology & Metabolism
  115. Reproductive Outcomes and Nononcologic Complications After Radioactive Iodine Ablation for Well-Differentiated Thyroid Cancer
    James X. Wu, Stephanie Young, Kevin Ro, Ning Li, Angela M. Leung, Harvey Kenn Chiu, Avital Harari, Michael W. Yeh · 2014 · Thyroid
  116. Clinical Features and Outcome of the Tall Cell Variant of Papillary Thyroid Carcinoma
    Alex Leung, Sin‐Ming Chow, Stephen C.K. Law · 2008 · The Laryngoscope
  117. I-123 Diagnostic Thyroid Tumor Whole-Body Scanning with Imaging at 6, 24, and 48 Hours
    Stephen K. Gerard, Ralph R. Cavalieri · 2002 · Clinical Nuclear Medicine
  118. Survival impact of treatment options for papillary microcarcinoma of the thyroid
    Harrison W. Lin, Neil Bhattacharyya · 2009 · The Laryngoscope
  119. Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Iain James Nixon, Frank L. Palmer, Monica M. Whitcher, Ashok R. Shaha, Jatin P. Shah, Snehal G. Patel, Ian Ganly · 2010 · Annals of Surgical Oncology
  120. Prognosis of low-risk papillary thyroid carcinoma patients: Its relationship with the size of primary tumors
    Yasuhiro Ito, Takumi Kudo, Minoru Kihara · 2011 · Endocrine Journal
  121. A Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: Clinical and Pathologic Features and Outcomes of 34 Consecutive Cases
    Concetto Regalbuto, Pasqualino Malandrino, Andrea Tumminia · 2011 · Thyroid
  122. Poorly Differentiated Follicular Thyroid Carcinoma: Prognostic Factors and Relevance of Histological Classification
    Melania Pulcrano, Houda Boukheris, Monique Talbot · 2007 · Thyroid
  123. Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care
    Thyroid Cancer Alliance, Rita Banach, Beate Bartès, Kate Farnell, Harald Rimmele, Joan Shey, Susanne Singer, Frederik A. Verburg, Markus Luster · 2013 · HORMONES
  124. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas
    Chao-Chun Huang, Chuen Hsueh, Feng-Hsuan Liu, Tzu‐Chieh Chao, Jen‐Der Lin · 2009 · Surgical Oncology
  125. Serum Antithyroglobulin Antibodies Interfere with Thyroglobulin Detection in Fine-Needle Aspirates of Metastatic Neck Nodes in Papillary Thyroid Carcinoma
    Min Ji Jeon, Jee Won Park, Ji Min Han, Ji Hye Yim, Dong Eun Song, Gyungyub Gong, Tae Yong Kim, Jung Hwan Baek, Jeong Hyun Lee, Young Kee Shong et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
  126. Lithium as an Adjuvant of lodine-131 Uptake when Treating Patients with Well-Differentiated Thyroid Carcinoma
    Francisca Pons, Ignasi Carri�, Montserrat Estorch, M. Ginjaume, J PONS, René Llapur Milián · 1987 · Clinical Nuclear Medicine
  127. Lack of Association between Urinary Iodine Excretion and Successful Thyroid Ablation in Thyroid Cancer Patients
    Hernán Tala, Maria Grazia Castagna, Carla Fioravanti, Claudia Cipri, Ernesto Brianzoni, Furio Pacini · 2009 · The Journal of Clinical Endocrinology & Metabolism
  128. Serum Thyrotropin (TSH) Levels after Thyroid Ablation Compared with TSH Levels after Exogenous Bovine TSH: Implications for131I Treatment of Thyroid Carcinoma
    Jerome M. Hershman, C. LOWELL EDWARDS · 1972 · The Journal of Clinical Endocrinology & Metabolism
  129. Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation
    C. Nascimento, Isabelle Borget, Frédéric Troalen, Abir Al Ghuzlan, Désirèe Deandreis, Dana M. Hartl, J. Lumbroso, C. Chougnet, Éric Baudin, Martin Jean Schlumberger et al. · 2013 · European Journal of Endocrinology
  130. THE URINARY EXCRETION AND THYROID UPTAKE OF IODINE IN RENAL DISEASE 1
    William F. Perry, John F. S. Hughes · 1952 · Journal of Clinical Investigation
  131. Prognostic value of the tall cell variety of papillary cancer of the thyroid.
    Alfredo Moreno Egea, J M Rodriguez Gonzalez, J Sola Perez · 1993 · PubMed
  132. Thyroglobulin in the Washout Fluid of Lymph-Node Biopsy: What Is Its Role in the Follow-Up of Differentiated Thyroid Carcinoma?
    Maria Roseneide dos Santos Torres, Sebastião Horácio Nóbrega Neto, Rosalina Jenner Rosas, Aline Lemos Barros Martins, André Luis Correia Ramos, Thomaz Rodrigues Porto da Cruz · 2013 · Thyroid
  133. Clinical, Safety, and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review
    Roger T. Anderson, John E. Linnehan, Vanita Tongbram, Karen N. Keating, Lori J. Wirth · 2013 · Thyroid
  134. Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 Therapy
    William G. Spies, CONSTANCE H. WOJTOWICZ, STEWART M. SPIES, ALKA Y. SHAH, Aline Zimmer · 1989 · Clinical Nuclear Medicine
  135. Detection of Thyrotropin-Receptor Messenger Ribonucleic Acid (mRNA) and Thyroglobulin mRNA Transcripts in Peripheral Blood of Patients with Thyroid Disease: Sensitive and Specific Markers for Thyroid Cancer
    Priya Chinnappa, Leslie Taguba, Rosemarie Arciaga, Charles Faiman, ALLAN E. SIPERSTEIN, Adi Mehta, Sethu K. Reddy, Christian E. Nasr, Manjula K. Gupta · 2004 · The Journal of Clinical Endocrinology & Metabolism
  136. Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine131I and Recombinant Human Thyroid Stimulating Hormone
    Amiel Z. Rudavsky, Leonărd M. Freeman · 1997 · The Journal of Clinical Endocrinology & Metabolism
  137. American Thyroid Association Statement on the Essential Elements of Interdisciplinary Communication of Perioperative Information for Patients Undergoing Thyroid Cancer Surgery
    Sally E. Carty, Gerard M. Doherty, William B. Inabnet · 2012 · Thyroid
  138. Encapsulated Classic and Follicular Variants of Papillary Thyroid Carcinoma: Comparative Clinicopathologic Study
    Zubair Wahid Baloch, Khurram Shafique, Melina B. Flanagan · 2010 · Endocrine Practice
  139. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
    Paul Bernard Romesser, Eric Jeffrey Sherman, Ashok R. Shaha, Ming Lian, Richard J. Wong, Mona M. Sabra, Shyam S. D. Rao, James A. Fagin, Robert Michael Tuttle, Nancy Y. Lee · 2014 · Journal of Surgical Oncology
  140. Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study
    Hanna Pelttari, Matti J. Välimäki, Eliisa Löyttyniemi, Camilla Schalin‐Jäntti · 2010 · European Journal of Endocrinology
  141. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
    Chao Ma, Jiawei Xie, Anren Kuang · 2005 · PubMed
  142. Rehospitalization among Elderly Patients with Thyroid Cancer after Thyroidectomy are Prevalent and Costly
    Charles T. Tuggle, Lesley S. Park, Sanziana A. Roman, Robert Udelsman, Julie Ann Sosa · 2010 · Annals of Surgical Oncology
  143. Exploring the relationship between severity of dysphonia and voice‐related quality of life
    S. M. Jones, P. Carding, M. Drinnan · 2006 · Clinical Otolaryngology
  144. High or low dose radioiodine ablation of thyroid remnants?
    Hans Creutzig · 1987 · European Journal of Nuclear Medicine and Molecular Imaging
  145. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma
    Yoko Kondo, Shigeki Arii, Masaharu Furutani, Shun‐Ichi Isigami, Akira Mori, Hisashi Onodera, Tsutomu Chiba, Masayuki Imamura · 2000 · Cancer
  146. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration
    Patrizia Agretti, Eleonora Ferrarini, Teresa Rago, Antonio Candelieri, Giuseppina De Marco, Antonio Dimida, Filippo Niccolai, Angelo Molinaro, G. Di Coscio, Aldo Pinchera et al. · 2012 · European Journal of Endocrinology
  147. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
    J P Muratet, P. Giraud, Alain Daver, J.F. Minier, Erick C. Gamelin, F Larra · 1997 · PubMed
  148. Use of Radioactive Iodine for Thyroid Remnant Ablation in Well-Differentiated Thyroid Carcinoma to Replace Thyroid Reoperation
    Jui‐Hsiang Lin, Tzu‐Chieh Chao, M. J. Huang, Hsiao‐Fen Weng, Kai‐Yuan Tzen · 1998 · American Journal of Clinical Oncology
  149. Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.
    S Costa, Gioacchino Giugliano, Luigi Santoro, André Ywata de Carvalho, Maria Angela Massaro, Bianca Gibelli, Elvio De Fiori, Enrica Grosso, Mohssen Ansarin, Luca Salvatore Calabrese · 2009 · PubMed Central
  150. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia
    Mihir K. Bhayani, Varun Acharya, Suchada Kongkiatkamon, Sally Farah, Dianna B. Roberts, Jennifer Sterba, Mark Steven Chambers, Stephen Yenzen Lai · 2015 · Thyroid
  151. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients
    Melanie R. Goldfarb, Jacqueline Casillas · 2014 · Journal of Cancer Survivorship
  152. Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes
    Yusuke Mizukami, Masakuni Noguchi, Takatoshi Michigishi · 1992 · Histopathology
  153. Clinical and Cytological Features Predictive of Malignancy in Thyroid Follicular Neoplasms
    Carrie Cunningham Lubitz, William C. Faquin, Jingyun Yang, Michal Mekel, Randall D. Gaz, Sareh Parangi, Gregory William Randolph, Richard A. Hodin, Antonia E. Stephen · 2009 · Thyroid
  154. Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension
    Ji Min Han, Won Gu Kim, Tae Yong Kim, Min Ji Jeon, Jin‐Sook Ryu, Dong Eun Song, Suck Joon Hong, Young Kee Shong, Won Bae Kim · 2013 · Thyroid
  155. Radiofrequency Ablation of Hepatic Metastases from Thyroid Carcinoma
    Marieke W.J.L.A.E. Wertenbroek, Thera P. Links, Ted R. Prins · 2008 · Thyroid
  156. Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma
    Marcia S. Brose, Johannes W. A. Smit, Jaume Capdevila, Rossella Elisei, Christopher M. Nutting, Fabián Pitoia, Bruce G. Robinson, Martin Jean Schlumberger, Young Kee Shong, Hiroshi E. Takami · 2012 · Expert Review of Anticancer Therapy
  157. Predictive Value of Sonographic Features in Preoperative Evaluation of Malignant Thyroid Nodules in a Multinodular Goiter
    Artür Salmaslıoğlu, Yeşim Erbil, Ahmet Cem Dural, Halim İşsever, Yersu Kapran, Selçuk Özarmağan, Serdar Tezelman · 2008 · World Journal of Surgery
  158. MRI Detection of Cervical Metastasis From Differentiated Thyroid Carcinoma
    Neil D. Gross, Jane L. Weissman, J. Michael Talbot · 2001 · The Laryngoscope
  159. Postoperative Stimulated Thyroglobulin of Less Than 1 ng/mL as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioactive Iodine Ablation
    Pedro Weslley Rosário, Augusto Flávio Campos Mineiro Filho, Brenda Sá Senna Prates, Lívia Cristina Oliveira Silva, Maria Regina Calsolari · 2012 · Thyroid
  160. Thyroid Nodules with Macrocalcification: Sonographic Findings Predictive of Malignancy
    Yun Joo Park, Jeong‐Ah Kim, Eun Ju Son · 2014 · Yonsei Medical Journal
  161. Radiofrequency ablation of bony metastatic disease
    Anthony Posteraro, Damian Edward Dupuy, William W. Mayo-Smith · 2004 · Clinical Radiology
  162. Therapeutic Sialendoscopy for the Management of Radioiodine Sialadenitis
    B. Prendes · 2012 · Archives of Otolaryngology - Head and Neck Surgery
  163. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Petri E. J. Voutilainen, Päivi Siironen, Kaarle Franssila · 2003 · PubMed
  164. Timing of Repeat Thyroid Fine-Needle Aspiration in the Management of Thyroid Nodules
    Remmi S. Singh, Helen H. Wang · 2011 · Acta Cytologica
  165. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Ḧurthle-cell neoplasms of the thyroid
    Insoo Suh, Menno R. Vriens, Marlon A. Guerrero · 2010 · The American Journal of Surgery
  166. BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Specimens Enhances the Predictability of Malignancy in Thyroid Follicular Lesions of Undetermined Significance
    Adebowale Adeniran, Pei Hui, David C. Chhieng, Manju Lata Prasad, Kevin Schofield, Constantine Theoharis · 2011 · Acta Cytologica
  167. Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?
    Babita Panigrahi, Sanziana A. Roman, Julie Ann Sosa · 2010 · Annals of Surgical Oncology
  168. Thyroid Papillary Carcinoma with Micropapillary and Hobnail Growth Pattern: A Histological Variant with Intermediate Malignancy?
    Utaroh Motosugi, Shin‐ichi Murata, Kohji Nagata · 2009 · Thyroid
  169. Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
    Eleonora Molinaro, Carlotta Giani, Laura Agate, Agnese Biagini, Letizia Pieruzzi, Francesca Bianchi, Federica Brozzi, Claudia Ceccarelli, David Viola, Paolo Piaggi et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism
  170. Five months’ follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 131I-SPECT/CT at the first radioablation
    Daniela Schmidt, Rainer Linke, Michael Uder · 2009 · European Journal of Nuclear Medicine and Molecular Imaging
  171. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma
    Sendia Kim · 2004 · Archives of Surgery
  172. Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin Values
    Richard T. Kloos · 2010 · The Journal of Clinical Endocrinology & Metabolism
  173. Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
    Robert Michael Tuttle, Norma Lopez, Rébecca Leboeuf, Shaye M. Minkowitz, Ravinder K. Grewal, Matvey Brokhin, Gal Omry, Steven M. Larson · 2010 · Thyroid
  174. Long-term outcomes of injection laryngoplasty in patients with potentially recoverable vocal fold paralysis1
    Lindsey Clemson Arviso, Michael M E Johns, Clyde C. Mathison · 2010 · The Laryngoscope
  175. Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears compared with FNAs prepared with ThinPrep alone
    Martin H. Luu, Andrew H. Fischer, Latha R. Pisharodi · 2010 · Cancer Cytopathology
  176. Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
    Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska‐Suwińska, Zbigniew Puch, Ewa Paliczka-Cieślik, Józef Roskosz, Daria Handkiewicz-Junak, Michał Jarząb, Elżbieta Gubała, Barbara Jarząb · 2010 · Thyroid Research
  177. Clinicopathologic Characteristics and Prognosis of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma in Japan: An 18‐Year Experience at a Single Institution
    Mitsuhiro Fukushima, Yasuhiro Ito, Mitsuyoshi Hirokawa, Haruki Akasu, Kazuo Shimizu, Akira Miyauchi · 2009 · World Journal of Surgery
  178. Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules
    F. Illouz, Patrice Rodien, Jean Paul Saint-André · 2007 · European Journal of Endocrinology
  179. Efficacy of Thyroid Hormone Suppression for Benign Thyroid Nodules: Meta‐Analysis of Randomized Trials
    Matthew T. Sdano, Mercedes Falciglia, Jeffrey A. Welge, David L. Steward · 2005 · Otolaryngology
  180. Low Specificity of Blood Thyroglobulin Messenger Ribonucleic Acid Assay Prevents Its Use in the Follow-Up of Differentiated Thyroid Cancer Patients
    Rossella Elisei, Agnese Vivaldi, Laura Agate, Eleonora Molinaro, Chiara Nencetti, Lucia Grasso, Aldo Pinchera, Furio Pacini · 2004 · The Journal of Clinical Endocrinology & Metabolism
  181. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: A population level study of 22,738 patients
    Eric J. Kuo, Sanziana A. Roman, Julie Ann Sosa · 2013 · Surgery
  182. Thyroid Nodular Disease in Pregnancy: Current Diagnosis and Management
    Irving B. Rosen, MARK KORMAN, Paul G. Walfish · 1997 · Clinical Obstetrics & Gynecology
  183. Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence
    David E. Gyorki, Brian R. Untch, Robert Michael Tuttle, Ashok R. Shaha · 2013 · Annals of Surgical Oncology
  184. Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy 131 I Whole-Body Scans
    Mona M. Sabra, Ravinder K. Grewal, Hernán Tala, Steven M. Larson, Robert Michael Tuttle · 2012 · Thyroid
  185. Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study
    Adebowale Adeniran, Constantine Theoharis, Pei Hui, Manju Lata Prasad, Lynwood W. Hammers, Tobias Carling, Robert Udelsman, David C. Chhieng · 2011 · Thyroid
  186. Thyroid Carcinomas With Distant Metastases
    Myriam Decaussin, Marie Hélène Bernard, Patrice Adeleine · 2002 · The American Journal of Surgical Pathology
  187. The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.
    Maria Grazia Castagna, Hernán Tala, C. Cipri, Valentina Belardini, Carla Fioravanti, Letizia Pasqui, Fausta Sestini, Alexandra Theodoropoulou, Furio Pacini · 2011 · PubMed
  188. Thyroglobulin measurement before rhTSH‐aided 131I ablation in detecting metastases from differentiated thyroid carcinoma
    Luca Giovanella, Luca Ceriani, Sergio Suriano · 2008 · Clinical Endocrinology
  189. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies
    Y.Y. Liu, Gabri van der Pluijm, Marcel Karperien, Marcel P. M. Stokkel, Alberto M. Pereira, J. Morreau, Job Kievit, Johannes Anthonius Romijn, Johannes W. A. Smit · 2006 · Clinical Endocrinology
  190. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: Experience of a major health care provider
    Wendy E. Hoy · 1996 · Cancer
  191. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates
    M KARAM, Andrew George Gianoukakis, Paul J. Feustel · 2003 · Nuclear Medicine Communications
  192. Recurrent Differentiated Thyroid Cancer
    Ashok R. Shaha · 2012 · Endocrine Practice
  193. Incremental Diagnostic Value of SPECT/CT with131I Scintigraphy after Radioiodine Therapy in Patients with Well-differentiated Thyroid Carcinoma
    Yasuhiro Maruoka, Koichiro Abe, Shingo Baba, Takuro Isoda, Hirofumi Sawamoto, Yoshitaka Tanabe, Masayuki Sasaki, Hiroshi Honda · 2012 · Radiology
  194. Insular thyroid cancer
    Hadiza Shu’aib Kazaure, Sanziana A. Roman, Julie Ann Sosa · 2012 · Cancer
  195. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
    Luca Giovanella, Franco Keller, Luca Ceriani, Renato Tozzoli · 2009 · Clinical Chemistry and Laboratory Medicine (CCLM)
  196. Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
    Ji Min Han, Won Bae Kim, Ji Hye Yim, Won Bae Kim, Tae Yong Kim, Jin‐Sook Ryu, Gyungyub Gong, Tae‐Yon Sung, Jong Ho Yoon, Suck Joon Hong et al. · 2012 · Thyroid
  197. Prognosis of Patients with Papillary Thyroid Carcinoma Showing Postoperative Recurrence to the Central Neck
    Yasuhiro Ito, Takuya Higashiyama, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya, Akira Miyauchi · 2010 · World Journal of Surgery
  198. A Low Postoperative Nonstimulated Serum Thyroglobulin Level Does Not Exclude the Presence of Radioactive Iodine Avid Metastatic Foci in Intermediate-Risk Differentiated Thyroid Cancer Patients
    Eyal Robenshtok, Ravinder K. Grewal, Stephanie A. Fish, Mona M. Sabra, Robert Michael Tuttle · 2012 · Thyroid
  199. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer
    N. Lima, Humberto Cavaliere, Eduardo Kiyoshi Tomimori, Meyer Knobel, Geraldo A. Medeiros-Neto · 2002 · Journal of Endocrinological Investigation
  200. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma
    Ji In Lee, Yun Jae Chung, Bo Youn Cho, Semin Chong, Ju Won Seok, Sung Jun Park · 2013 · Surgery